Evaluation of the coagulation properties of arginine-chitosan/DNA nanoparticles

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 95 B, Issue 2, 2010, Pages 374-379

  Song, Liping ^a   Zhu, Dunwan ^a   Liu, Lanxia ^a   Dong, Xia ^a   Zhang, Hailing ^a   Leng, Xigang ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

arginine; blood coagulation; chitosan; DNA nanoparticle; gene delivery

Indexed keywords

ANTICOAGULANT PROPERTIES; ARGININE; BLOOD COAGULATION; BODY WEIGHT; COAGULATION PROPERTIES; DIRECT CONTACT; DNA NANOPARTICLE; GENE DELIVERY; HEMOCOMPATIBILITY; IN-VITRO; INTRAVENOUS INJECTIONS; PROTHROMBIN TIME; THROMBIN TIME; TRANS-GENES;

BLOOD; CHITIN; CHITOSAN; COAGULATION; DNA; GENE THERAPY; GENE TRANSFER; NANOPARTICLES;

AMINO ACIDS;

ARGININE; ARGININE CHITOSAN CONJUGATE; ARGININE CHITOSAN DNA NANOPARTICLE CONJUGATE; CHITOSAN; CHITOSAN GENE NANOPARTICLE CONJUGATE; NANOPARTICLE; PLASMID DNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; BIOCOMPATIBILITY; BLOOD CLOTTING; CONCENTRATION (PARAMETERS); CONJUGATE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; HEMATOLOGICAL PARAMETERS; HEMOLYSIS; HUMAN; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RAT; THROMBIN TIME; TRANSGENE;

ARGININE; BLOOD COAGULATION; CHITOSAN; DNA; HEMOLYSIS; HEMOSTATICS; HUMANS; NANOPARTICLES;

EID: 78649680797     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31726     Document Type: Article

References (37)

1. Jooss K, Chirmule N,. Immunity to adenovirus and adeno-associated viral vectors: Implications for gene therapy. Gene Ther 2003; 10: 955-963.
2. Cristiano RJ, Smith LC, Kay MA, Brinkley BR, Woo SL,. Hepatic gene therapy: Efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex. Proc Natl Acad Sci USA 1993; 90: 11548-11552.
3. Nathwani AC, Davidoff AM, Hanawa H, Hu Y, Hoffer FA, Nikanorov A, Slaughter C, Ng CY, Zhou J, Lozier JN, Mandrell TD, Vanin EF, Nienhuis AW,. Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood 2002; 100: 1662-1669.
4. Cheung ST, Tsui TY, Wang WL, Yang ZF, Wong SY, Ip YC, Luk J, Fan ST,. Liver as an ideal target for gene therapy: expression of CTLA4Ig by retroviral gene transfer. J Gastroenterol Hepatol 2002; 17: 1008-1014.
5. Treco DA, Selden RF,. Non-viral gene therapy. Mol Med Today 1995; 1: 314-321.
6. Cichon G, Schmidt HH, Benhidjeb T, Loser P, Ziemer S, Haas R, Grewe N, Schnieders F, Heeren J, Manns MP, Schlag PM, Strauss M,. Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits. J Gene Med 1999; 1: 360-371.
7. Bloomfield VA,. DNA condensation. Curr Opin Struct Biol 1996; 6: 334-341.
8. MacLaughlin FC, Mumper RJ, Wang J, Tagliaferri JM, Gill I, Hinchcliffe M, Rolland AP,. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Control Release 1998; 56: 259-272.
9. Richardson SC, Kolbe HV, Duncan R,. Potential of low molecular mass chitosan as a DNA delivery system: Biocompatibility, body distribution and ability to complex and protect DNA. Int J Pharm 1999; 178: 231-243.
10. Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, August JT, Leong KW,. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 2001; 70: 399-421.
11. Liu WG, Yao KD,. Chitosan and its derivatives-A promising non-viral vector for gene transfection. J Control Release 2002; 83: 1-11.
12. Mansouri S, Lavigne P, Corsi K, Benderdour M, Beaumont E, Fernandes JC,. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: Strategies to improve transfection efficacy. Eur J Pharm Biopharm 2004; 57: 1-8.
13. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM,. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 2004; 100: 5-28.
14. Erbacher P, Zou S, Bettinger T, Steffan AM, Remy JS,. Chitosan-based vector/DNA complexes for gene delivery: Biophysical characteristics and transfection ability. Pharm Res 1998; 15: 1332-1339.
15. Corsi K, Chellat F, Yahia L, Fernandes JC,. Mesenchymal stem cells. MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials 2003; 24: 1255-1264.
16. Kaplan IM, Wadia JS, Dowdy SF,. Cationic TAT peptide transduction domain enters cells by macropinocytosis. J Control Release 2005; 102: 247-253.
17. Cardarelli F, Serresi M, Bizzarri R, Giacca M, Beltram F,. In vivo study of HIV-1 Tat arginine-rich motif unveils its transport properties. Mol Ther 2007; 15: 1313-1322.
18. Binder H, Lindblom G,. A molecular view on the interaction of the trojan peptide penetratin with the polar interface of lipid bilayers. Biophys J 2004; 87: 332-343.
19. Zheng C, Brownlie R, Babiuk LA, van Drunen Littel-van den Hurk S,. Characterization of the nuclear localization and nuclear export signals of bovine herpesvirus 1 VP22. J Virol 2005; 79: 11864-11872.
20. Gupta B, Torchilin VP,. Transactivating transcriptional activator-mediated drug delivery. Expert Opin Drug Deliv 2006; 3: 177-190.
21. Zhang HL, Zhu DW, Yang J, Song LP, Bo JG, Yao KD, Leng XG,. Cellular uptake and cytotoxicity of modified chitosans as gene carriers. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006; 28: 486-491.
22. Zhu DW, Zhang HL, Bai JG, Liu WG, Leng XG, Song CX, Yang J, Li XW, Jin X, Song LP,. Enhancement of transfection efficiency for HeLa cells via incorporating arginine moiety into chitosan. Chinese Sci Bull 2007; 52: 3207-3215.
23. Malette WG, Quigley HJ Jr,. Method of achieving hemostasis. In, US Patents; 1983.
24. Klokkevold PR, Lew DS, Ellis DG, Bertolami CN,. Effect of chitosan on lingual hemostasis in rabbits. J Oral Maxillofac Surg 1991; 49: 858-863.
25. Hoekstra A, Struszczyk H, Kivekas O,. Percutaneous microcrystalline chitosan application for sealing arterial puncture sites. Biomaterials 1998; 19: 1467-1471.
26. Cochrum KC, Parker HR, Chiu MMC,. Fibrinogen/chitosan hemostatic agents. In, US Patents; 1998.
27. Yang J, Tian F, Wang Z, Wang Q, Zeng YJ, Chen SQ,. Effect of chitosan molecular weight and deacetylation degree on hemostasis. J Biomed Mater Res B Appl Biomater 2008; 84: 131-137.
28. Wang QZ, Chen XG, Li ZX, Wang S, Liu CS, Meng XH, Liu CG, Lv YH, Yu Le J,. Preparation and blood coagulation evaluation of chitosan microspheres. J Mater Sci Mater Med 2008; 19: 1371-1377.
29. Liu LX, Song CN, Song LP, Zhang HL, Dong X, Leng XG,. Effects of alkylated-chitosan-DNA nanoparticles on the function of macrophages. J Mater Sci Mater Med 2009; 20: 943-948.
30. Erlich J, Fearns C, Mathison J, Ulevitch RJ, Mackman N,. Lipopolysaccharide induction of tissue factor expression in rabbits. Infect Immun 1999; 67: 2540-2546.
31. Riewald M, Ruf W,. Science review: Role of coagulation protease cascades in sepsis. Crit Care 2003; 7: 123-129.
32. Fukasawa M, Abe H, Masaoka T, Orita H, Horikawa H, Campeau JD, Washio M,. The hemostatic effect of deacetylated chitin membrane on peritoneal injury in rabbit model. Surg Today 1992; 22: 333-338.
33. Nemmar A, Hoylaerts MF, Hoet PH, Dinsdale D, Smith T, Xu H, Vermylen J, Nemery B,. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med 2002; 166: 998-1004.
34. Nemmar A, Hoylaerts MF, Hoet PH, Vermylen J, Nemery B,. Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. Toxicol Appl Pharmacol 2003; 186: 38-45.
35. Liu WG, Zhang JR, Cao ZQ, Xu FY, Yao KD,. A chitosan-arginine conjugate as a novel anticoagulation biomaterial. J Mater Sci Mater Med 2004; 15: 1199-1203.
36. Amiji MM,. Platelet adhesion and activation on an amphoteric chitosan derivative bearing sulfonate groups. Colloids Surf B Biointerfaces 1998; 10: 263-271.
37. Hirano S, Zhang M, Nakagawa M, Miyata T,. Wet spun chitosan-collagen fibers, their chemical N-modifications, and blood compatibility. Biomaterials 2000; 21: 997-1003.